bioMérieux S.A.
OTC: BMXXY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Pierre Boulud
- Employees
- 14,147
- Headquarters
- Marcy l'Étoile, France
- IPO year
- 2023
- Market cap
- $8.4B
- Website
- https://www.biomerieux.com
Loading BMXXY…
Loading profile data…Frequently asked questions about BMXXY
What does bioMérieux S.A. (BMXXY) do?
bioMérieux S.A. is a global leader in the development and production of in vitro diagnostic solutions, primarily aimed at detecting infectious diseases. Its operations span the Americas, Europe, the Middle East, Africa, and the Asia Pacific regions. The company provides sophisticated diagnostic platforms that analyze biological specimens to pinp...
Where does BMXXY trade?
bioMérieux S.A. (BMXXY) trades on the Other OTC.
What sector is BMXXY in?
bioMérieux S.A. (BMXXY) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of bioMérieux S.A.?
Pierre Boulud is the chief executive officer of bioMérieux S.A. (BMXXY).
Where is bioMérieux S.A. headquartered?
bioMérieux S.A. is headquartered in France.
Does BMXXY pay a dividend?
Yes — bioMérieux S.A. (BMXXY) paid a trailing twelve-month dividend of USD 0.11 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BMXXY go public?
bioMérieux S.A. (BMXXY) completed its initial public offering in 2023.
Is BMXXY an ADR?
Yes — BMXXY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. bioMérieux S.A. reporting and dividends follow the underlying issuer.